Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
THE NHS England/NICE consultation on reform of the Cancer Drugs Fund closed 11/02/16.
Cancer Research UK has responded.
Sir Harpal Kumar, Cancer Research UK’s chief executive, said: “The Cancer Drugs Fund hasn’t been fit for purpose for some time so the proposed reforms are a promising step that Cancer Research UK support.
NHS England and NICE should now work to clarify details of these proposals so the system can be transformed without delay."
“We believe that making these changes will provide greater certainty to patients on the drugs that are available to them. Central to this new approach is greater discretion for the NHS to find out more about a medicine, where there’s uncertainty if it is a genuine breakthrough. We need a system that acts faster, can manage the budget and collects better data on how these drugs help patients."
“We hope that NICE and pharmaceutical companies will work together so that these changes bring life-saving drugs to patients sooner. It’s crucial that patients don’t miss out while the CDF is undergoing its changes.”
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.